dihexa for high blood pressure Peptide Therapy Dihexa: Built for memory and

We create a brain that is actually capable of learning from the therapy

LIFT-AD Phase 2/3 Failure The larger LIFT-AD trial fails both primary and key secondary endpoints, raising questions about the clinical viability of fosgonimeton

Activating the HGF/c-Met signaling pathway initiates a cascade of events that: Stimulates synaptogenesis the physical formation of new synaptic connections between neurons Promotes dendritic spine formation the small protrusions on neurons essential for receiving signals Enhances synaptic density in brain regions associated with learning and memory Supports neural stem cell activity and neuroplasticity Reduces neuroinflammatory signaling, offering a neuroprotective effect Structural vs

When all participants were analyzed regardless of treatment adherence, weight reduction trends were consistent with those from the primary analysis, confirming robustness of the findings